Keyphrases
Bispecific T-cell Engager (BiTE)
100%
Glioblastoma
100%
T Cells
35%
Glioblastoma Cells
23%
Host Immune Response
17%
Tumor Uptake
11%
T-cell Mediated
11%
Activated T Cells
11%
Solid Tumors
11%
Tumor Treating Fields
5%
Direct Killing
5%
Glioblastoma Therapy
5%
Tumor Pharmacokinetics
5%
ScFv
5%
Glioma Model
5%
Glioblastoma multiforme
5%
Human Model
5%
Malignancy
5%
Cell Surface Receptor
5%
Brain Cells
5%
Clinical Application
5%
Successful Completion
5%
Treatment Regimen
5%
New Targeted Therapy
5%
Therapeutic Response
5%
Cell-to-cell
5%
Rational Design
5%
Dependent Processes
5%
Glioma Cells
5%
Tumor Therapeutics
5%
Improved Outcomes
5%
Murine Model
5%
Antitumor
5%
Antitumor Activity
5%
Incurable Cancer
5%
Cancer Cells
5%
Specific Intent
5%
Combined Modality Therapy
5%
Biodistribution
5%
Mechanism of Action
5%
Single-chain Antibody
5%
Imaging Data
5%
Blood-tumor Barrier
5%
Tumor Cells
5%
Survival Rate
5%
Tumor
5%
Radiation Chemotherapy
5%
Preclinical Data
5%
Immune Function
5%
Therapy Types
5%
Normal Brain
5%
Tumor Immunity
5%
Early Development
5%
Tumor Mechanism
5%
Syngeneic
5%
Tumor Microenvironment
5%
Medicine and Dentistry
Glioblastoma
100%
T Cell
100%
Neoplasm
42%
Solid Malignant Neoplasm
14%
Immune Function
7%
Single Chain Fragment Variable Antibody
7%
Pharmacokinetics
7%
Cell Surface Receptor
7%
Cancer Cell
7%
Treatment Response
7%
Tumor Treating Fields
7%
Tumor Microenvironment
7%
Targeted Therapy
7%
Cancer
7%
Survival Rate
7%
Glioma Cell
7%
Tumor Immunity
7%
Immune Response
7%
Brain Cell
7%
Malignant Neoplasm
7%
Biodistribution
7%
Immune System
7%
Antineoplastic Activity
7%
Tumor Cell
7%
Clinical Study
7%
Chemotherapy
7%
CD3 Antigen
7%
Immunology and Microbiology
T Cell
100%
Host Immune Response
8%
Immune System
8%
Cancer Cell
8%
Antineoplastic Activity
8%
Pharmacokinetics
8%
Single-Chain Variable Fragment
8%
Tumor Immunity
8%
Syngenic
8%
CD3 Antigen
8%
Cell Surface
8%
Survival Rate
8%
Glioma Cell
8%
Immunity
8%
Tumor Cell
8%
Brain Cell
8%